Overcoming barriers to monitoring patients taking second-generation antipsychotics

INTRODUCTION: Patients taking second-generation antipsychotics (SGAs) are at increased risk of developing metabolic syndrome because of the side effect profiles of these medications. A medication use evaluation (MUE) was conducted and showed that baseline monitoring rates of metabolic parameters in...

Descripción completa

Detalles Bibliográficos
Autores principales: Peña, Anita, DeJongh, Beth, Haas, Matthew, Harms, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007736/
https://www.ncbi.nlm.nih.gov/pubmed/29955545
http://dx.doi.org/10.9740/mhc.2018.03.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007736/
https://www.ncbi.nlm.nih.gov/pubmed/29955545
http://dx.doi.org/10.9740/mhc.2018.03.049

Ejemplares similares